Biogen : BIIB

All Biogen Articles

606 Articles

Jon C. Ogg | Mar 12, 2010 at 8:38 AM EST

Top 10 Analyst Upgrades and Downgrades (ABT, ARO, BIIB, CELG, CADC, FACT, HBC, LMNX, EDU, SGI)

These are this Friday’s top analyst upgrades, downgrades, and initiations seen from Wall Street morning research calls: Abbott Laboratories (NYSE:…

Douglas A. McIntyre | Mar 9, 2010 at 8:17 AM EST

Top 10 Analyst Upgrades and Downgrades (BIIB, CMA, ENER, ESLR, FSLR, MAT, HK, TRV, YUM, ZRAN)

These are this Tuesday morning’s top analyst upgrades, downgrades, and initiations seen in early Wall Street research notes: Biogen Idec…

Douglas A. McIntyre | Dec 21, 2009 at 1:42 PM EST

Unusual Options Trading Alerts (AAPL, GOOG, AMZN, RIMM, GLD, BIIB, MU)

We have compiled several options chains we are watching today now that the DEC-2009 PUTS/CALLS have expired on Friday. Much…

Douglas A. McIntyre | Nov 2, 2009 at 9:25 AM EST

Top 10 Analyst Upgrades, Downgrades, Initiations (BIIB, INCY, MOT, CMCSA, JWN, ODP, PALM, RIMM, RCL, YUM)

These are this Monday’s top ten analyst upgrades, downgrades, and initiations seen from Wall Street research firms: Biogen Idec (NASDAQ:…

Douglas A. McIntyre | Sep 4, 2009 at 3:48 PM EDT

BioTech Hostile Takeover: Biogen Plays For Facet

Facet Biotech Corporation (FACT) confirms that it is in receipt of Biogen Idec Inc.’s (BIIB) letter dated September 4, 2009…

Douglas A. McIntyre | Sep 2, 2009 at 8:21 AM EDT

Top Analyst Upgrades and Downgrades (BIIB, FRX, GENZ, GILD, HOLX, LVS, MOS, NVAX, RIG, TXT)

These are the top ten analyst research initiations, upgrades, and downgrades we have seen from top Wall Street firms early…

Douglas A. McIntyre | Aug 24, 2009 at 9:54 AM EDT

When Key Biotechs Have Low P/E’s & Value Screens (AMGN, BIIB, CEPH, CBST, GENZ, PDLI)

It usually takes an event or a series of events for biotech stocks to ever look cheap compared to the…

Douglas A. McIntyre | Aug 7, 2009 at 4:05 AM EDT

Media Digest 8/7/2009 Reuters, WSJ, NY Times, FT, Bloomberg

Reuters: A college education no longer means easy employment in China. Reuters: Fannie Mae (FNM) lost $14.8 billion. Reuters: The…

Douglas A. McIntyre | Jul 22, 2009 at 4:01 AM EDT

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line…

Douglas A. McIntyre | Jul 10, 2009 at 10:07 AM EDT

Biotech Business Daily (BIIB, VRTX, ALNY, STEM)

Here are some of the top stories affecting key drug and biotech stocks this Friday. We also have links through…

Douglas A. McIntyre | Jul 9, 2009 at 11:09 AM EDT

Biotech Business Daily (RIGL, BIIB, ARRY, ALNY, FOLD, HALO, AOB, STEM)

Here are some of the top stories affecting key drug and biotech stocks that have links through to more in-depth…

Douglas A. McIntyre | Jun 30, 2009 at 3:03 AM EDT

Media Digest 8/30/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters: Cybercrime is spreading fast on Facebook. Reuters: GM will seek to sell most of its assets to a new company.…

Douglas A. McIntyre | Jun 10, 2009 at 3:02 AM EDT

Media Digest 6/10/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters: The Supreme Court delays Chrysler deal. Reuters: The cleared ten banks to repay TARP include JPMorgan (JPM), Goldmand Sachs…

Douglas A. McIntyre | Jun 5, 2009 at 3:02 AM EDT

Media Digest 6/5/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters: Rio Tinto (RTP) has killed a deal with Chinalco for one with BHP (BHP). Reuters: US regulators insisted JP…

Douglas A. McIntyre | Apr 17, 2009 at 2:05 PM EDT

Weekend of Cancer Data at AACR Ahead of ASCO (ALTH, AMGN, ARIA, ARRY, AZN, BIIB, CELG, CRIS, IMMU, IMGN, INFI, MEDX, MNTA, ONCY, PFE, PCYC, SUPG, TELK, THLD)

This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks. The American Association…

1 … 35 36 37 38 39 … 41

Biogen : BIIB

All Biogen Articles

Top 10 Analyst Upgrades and Downgrades (ABT, ARO, BIIB, CELG, CADC, FACT, HBC, LMNX, EDU, SGI)

Top 10 Analyst Upgrades and Downgrades (BIIB, CMA, ENER, ESLR, FSLR, MAT, HK, TRV, YUM, ZRAN)

Unusual Options Trading Alerts (AAPL, GOOG, AMZN, RIMM, GLD, BIIB, MU)

Top 10 Analyst Upgrades, Downgrades, Initiations (BIIB, INCY, MOT, CMCSA, JWN, ODP, PALM, RIMM, RCL, YUM)

BioTech Hostile Takeover: Biogen Plays For Facet

Top Analyst Upgrades and Downgrades (BIIB, FRX, GENZ, GILD, HOLX, LVS, MOS, NVAX, RIG, TXT)

When Key Biotechs Have Low P/E’s & Value Screens (AMGN, BIIB, CEPH, CBST, GENZ, PDLI)

Media Digest 8/7/2009 Reuters, WSJ, NY Times, FT, Bloomberg

The Next Blockbuster Drugs: A $170 Billion Opportunity

Biotech Business Daily (BIIB, VRTX, ALNY, STEM)

Biotech Business Daily (RIGL, BIIB, ARRY, ALNY, FOLD, HALO, AOB, STEM)

Media Digest 8/30/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Media Digest 6/10/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Media Digest 6/5/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Weekend of Cancer Data at AACR Ahead of ASCO (ALTH, AMGN, ARIA, ARRY, AZN, BIIB, CELG, CRIS, IMMU, IMGN, INFI, MEDX, MNTA, ONCY, PFE, PCYC, SUPG, TELK, THLD)

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Biogen : BIIB

All Biogen Articles

Top 10 Analyst Upgrades and Downgrades (ABT, ARO, BIIB, CELG, CADC, FACT, HBC, LMNX, EDU, SGI)

Top 10 Analyst Upgrades and Downgrades (BIIB, CMA, ENER, ESLR, FSLR, MAT, HK, TRV, YUM, ZRAN)

Unusual Options Trading Alerts (AAPL, GOOG, AMZN, RIMM, GLD, BIIB, MU)

Top 10 Analyst Upgrades, Downgrades, Initiations (BIIB, INCY, MOT, CMCSA, JWN, ODP, PALM, RIMM, RCL, YUM)

BioTech Hostile Takeover: Biogen Plays For Facet

Top Analyst Upgrades and Downgrades (BIIB, FRX, GENZ, GILD, HOLX, LVS, MOS, NVAX, RIG, TXT)

When Key Biotechs Have Low P/E’s & Value Screens (AMGN, BIIB, CEPH, CBST, GENZ, PDLI)

Media Digest 8/7/2009 Reuters, WSJ, NY Times, FT, Bloomberg

The Next Blockbuster Drugs: A $170 Billion Opportunity

Biotech Business Daily (BIIB, VRTX, ALNY, STEM)

Biotech Business Daily (RIGL, BIIB, ARRY, ALNY, FOLD, HALO, AOB, STEM)

Media Digest 8/30/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Media Digest 6/10/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Media Digest 6/5/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Weekend of Cancer Data at AACR Ahead of ASCO (ALTH, AMGN, ARIA, ARRY, AZN, BIIB, CELG, CRIS, IMMU, IMGN, INFI, MEDX, MNTA, ONCY, PFE, PCYC, SUPG, TELK, THLD)

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do